title: [Therapeutic Effects of Berberine Capsule on Patients with Mild Hyperlipidemia].
abstract: OBJECTIVE
  To observe the therapeutic effects of Berberine Capsule (BC) on patients with mild hyperlipidemia.
  
  
  METHODS
  Totally 102 mild hyperlipemia patients were recruited. All patients were suggested to have proper diet and physical activity as basic therapy for 1 month of run-in period. Totally 97 patients completed it. Then they were randomly assigned to the berberine group (the treatment group, 49 cases) and the placebo group (the control group, 48 cases). Patients in the treatment group took BC 300 mg, while those in the control group took placebo 300 mg, thrice per day for 3 successive months. Then placebos and BC were interrupted for 2 months (as washout period). All subjects received only diet control and physical activity during washout period. After washout period, placebos and BC were re-administered to all patients in the same way for 3 months. Body mass index (BMI), fasting plasma glucose (FPG), TG, TC, LDL-C, and HDL-C were assessed after run-in period, washout period, at month 1, 2, 3 after the first therapy, at month 1, 2, 3 after second treatment, respectively.
  
  
  RESULTS
  Compared with the end of run-in period, TG, TC, and LDL-C decreased, and HDL-C increased in the treatment group (P < 0.05) after first 3 months of treatment. Compared with 3 months after the first therapy, TG, TC, and LDL-C increased and HDL-C decreased in the treatment group after washout period (P < 0.05). Compared with the end of wash- out period, TC and LDL-C decreased in the treatment group at month 2 after second treatment (P < 0.05); TG, TC, and LDL-C decreased (P < 0.01, P < 0.05), and HDL-C increased (P < 0.05) at month 3 after second treatment. Compared with the control group at month 3 after second treatment, TG, TC, and LDL-C all decreased, and HDL-C increased in the treatment group (all P < 0.05).
  
  
  CONCLUSIONS
  BC was effective in improving blood lipid level in mild hyperlipidemia patients.
authors.forename: Li
authors.initials: L
authors.lastname: Wang
authors.forename: Long-yun
authors.initials: LY
authors.lastname: Peng
authors.forename: Guo-hong
authors.initials: GH
authors.lastname: Wei
authors.forename: Hui
authors.initials: H
authors.lastname: Ge
mesh_terms: D001599:Berberine / Q000627:therapeutic use*; D001786:Blood Glucose / Q000032:analysis; D015992:Body Mass Index; D002214:Capsules; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy*; D008055:Lipids / Q000097:blood*
chemical_list: D001786:Blood Glucose; D002214:Capsules; D008055:Lipids; D001599:Berberine